400 related articles for article (PubMed ID: 26604636)
1. MicroRNA in inflammatory bowel disease: Translational research and clinical implication.
Fisher K; Lin J
World J Gastroenterol; 2015 Nov; 21(43):12274-82. PubMed ID: 26604636
[TBL] [Abstract][Full Text] [Related]
2. Functional role and therapeutic targeting of microRNAs in inflammatory bowel disease.
Soroosh A; Koutsioumpa M; Pothoulakis C; Iliopoulos D
Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G256-G262. PubMed ID: 29146677
[TBL] [Abstract][Full Text] [Related]
3. Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease.
Béres NJ; Kiss Z; Sztupinszki Z; Lendvai G; Arató A; Sziksz E; Vannay Á; Szabó AJ; Müller KE; Cseh Á; Boros K; Veres G
Dig Liver Dis; 2017 Apr; 49(4):378-387. PubMed ID: 28077249
[TBL] [Abstract][Full Text] [Related]
4. miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation.
Xu XM; Zhang HJ
World J Gastroenterol; 2016 Feb; 22(7):2206-18. PubMed ID: 26900285
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer.
James JP; Riis LB; Malham M; Høgdall E; Langholz E; Nielsen BS
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114313
[TBL] [Abstract][Full Text] [Related]
6. MiRNAs and inflammatory bowel disease: An interesting new story.
Moein S; Vaghari-Tabari M; Qujeq D; Majidinia M; Nabavi SM; Yousefi B
J Cell Physiol; 2019 Apr; 234(4):3277-3293. PubMed ID: 30417350
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs: how many in inflammatory bowel disease?
Schaefer JS
Curr Opin Gastroenterol; 2016 Jul; 32(4):258-66. PubMed ID: 27138057
[TBL] [Abstract][Full Text] [Related]
8. Deep Dive Into MicroRNAs in Inflammatory Bowel Disease.
Alfaifi J; Germain A; Heba AC; Arnone D; Gailly L; Ndiaye NC; Viennois E; Caron B; Peyrin-Biroulet L; Dreumont N
Inflamm Bowel Dis; 2023 Jun; 29(6):986-999. PubMed ID: 36545755
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in inflammatory bowel disease--pathogenesis, diagnostics and therapeutics.
Coskun M; Bjerrum JT; Seidelin JB; Nielsen OH
World J Gastroenterol; 2012 Sep; 18(34):4629-34. PubMed ID: 23002331
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
[TBL] [Abstract][Full Text] [Related]
11. Sparse Modeling Reveals miRNA Signatures for Diagnostics of Inflammatory Bowel Disease.
Hübenthal M; Hemmrich-Stanisak G; Degenhardt F; Szymczak S; Du Z; Elsharawy A; Keller A; Schreiber S; Franke A
PLoS One; 2015; 10(10):e0140155. PubMed ID: 26466382
[TBL] [Abstract][Full Text] [Related]
12. [Potential relevance of microRNAs in the diagnostics of inflammatory bowel diseases].
Igaz I; Szőnyi M; Varga P; Topa L
Orv Hetil; 2014 Mar; 155(13):487-91. PubMed ID: 24659741
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-132 and microRNA-223 control positive feedback circuit by regulating FOXO3a in inflammatory bowel disease.
Kim HY; Kwon HY; Ha Thi HT; Lee HJ; Kim GI; Hahm KB; Hong S
J Gastroenterol Hepatol; 2016 Oct; 31(10):1727-1735. PubMed ID: 26878986
[TBL] [Abstract][Full Text] [Related]
14. Role of MiRNAs in Inflammatory Bowel Disease.
Cao B; Zhou X; Ma J; Zhou W; Yang W; Fan D; Hong L
Dig Dis Sci; 2017 Jun; 62(6):1426-1438. PubMed ID: 28391412
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs: new players in IBD.
Kalla R; Ventham NT; Kennedy NA; Quintana JF; Nimmo ER; Buck AH; Satsangi J
Gut; 2015 Mar; 64(3):504-17. PubMed ID: 25475103
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic biomarkers in inflammatory bowel disease].
Kanmura S; Sakiyama T; Uto H; Tsubouchi H
Nihon Rinsho; 2012 May; 70(5):790-5. PubMed ID: 22620002
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer.
Masi L; Capobianco I; Magrì C; Marafini I; Petito V; Scaldaferri F
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887337
[TBL] [Abstract][Full Text] [Related]
18. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.
Cătană CS; Berindan Neagoe I; Cozma V; Magdaş C; Tăbăran F; Dumitraşcu DL
World J Gastroenterol; 2015 May; 21(19):5823-30. PubMed ID: 26019446
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory bowel disease: beyond the boundaries of the bowel.
Actis GC; Rosina F; Mackay IR
Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):401-10. PubMed ID: 21651357
[TBL] [Abstract][Full Text] [Related]
20. DNA Methylation Profiling in Inflammatory Bowel Disease Provides New Insights into Disease Pathogenesis.
McDermott E; Ryan EJ; Tosetto M; Gibson D; Burrage J; Keegan D; Byrne K; Crowe E; Sexton G; Malone K; Harris RA; Kellermayer R; Mill J; Cullen G; Doherty GA; Mulcahy H; Murphy TM
J Crohns Colitis; 2016 Jan; 10(1):77-86. PubMed ID: 26419460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
